MyFinsight
Home
About
Contact
iart: the income statement
Download
Download image
Private Label
$25,491K
Regenerative Skin And Wound
$83,988K
ENT
$40,869K
Instruments
$50,151K
(-7.54%↓ Y/Y)
Neurosurgery
$201,563K
(14.55%↑ Y/Y)
Tissue Technologies
$109,479K
Codman Specialty
Surgical
$292,583K
Net loss
-$5,404K
(49.47%↑ Y/Y)
Benefit for income taxes
-$1,420K
(85.31%↑ Y/Y)
Total revenue, net
$402,062K
(5.57%↑ Y/Y)
Loss before income
taxes
-$6,824K
(66.49%↑ Y/Y)
Interest income
$4,982K
(-1.33%↓ Y/Y)
Operating income (loss)
$11,761K
(244.31%↑ Y/Y)
Total costs and
expenses
$390,301K
(0.34%↑ Y/Y)
Other (expense)
income, net
-$842K
(-139.87%↓ Y/Y)
Interest expense
$22,725K
(17.30%↑ Y/Y)
Intangible asset
amortization
$3,728K
(-0.85%↓ Y/Y)
Selling, general and
administrative
$169,046K
(-4.60%↓ Y/Y)
Research and development
$22,456K
(-18.15%↓ Y/Y)
Cost of goods sold
$195,071K
(8.02%↑ Y/Y)
Back
Back
Income Statement
source: myfinsight.com
INTEGRA LIFESCIENCES HOLDINGS CORP (IART)
INTEGRA LIFESCIENCES HOLDINGS CORP (IART)